4.7 Article

Genetic Variation in Innate Immunity and Inflammation Pathways Associated With Lung Cancer Risk

Related references

Note: Only part of the references are listed.
Article Oncology

Increased Risk of Lung Cancer in Men with Tuberculosis in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study

Meredith S. Shiels et al.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2011)

Article Oncology

Increased Levels of Circulating Interleukin 6, Interleukin 8, C-Reactive Protein, and Risk of Lung Cancer

Sharon R. Pine et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)

Article Oncology

Risk of Meningioma and Common Variation in Genes Related to Innate Immunity

Preetha Rajaraman et al.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2010)

Article Oncology

Chlamydia pneumoniae Infection and Risk for Lung Cancer

Anil K. Chaturvedi et al.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2010)

Review Pharmacology & Pharmacy

The NF-kappa B activation pathways, emerging molecular targets for cancer prevention and therapy

Yong Lin et al.

EXPERT OPINION ON THERAPEUTIC TARGETS (2010)

Article Genetics & Heredity

A Genome-wide Association Study of Lung Cancer Identifies a Region of Chromosome 5p15 Associated with Risk for Adenocarcinoma

Maria Teresa Landi et al.

AMERICAN JOURNAL OF HUMAN GENETICS (2009)

Article Oncology

Polymorphic Variation in NFKB1 and Other Aspirin-Related Genes and Risk of Hodgkin Lymphoma

Ellen T. Chang et al.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2009)

Article Biotechnology & Applied Microbiology

Polymorphisms in genes involved in the inflammatory response and interaction with NSAID use or smoking in relation to lung cancer risk in a prospective study

Ulla Vogel et al.

MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2008)

Article Genetics & Heredity

Lung cancer susceptibility locus at 5p15.33

James D. McKay et al.

NATURE GENETICS (2008)

Review Medicine, Research & Experimental

Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial

PC Prorok et al.

CONTROLLED CLINICAL TRIALS (2000)